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We report mutations in inﬂ  uenza A virus (H5N1) strains 
associated with 2 outbreaks in Turkey. Four novel amino 
acid changes (Q447L, N556K, and R46K in RNA poly-
merase and S133A in hemagglutinin) were detected in virus 
isolates from 2 siblings who died.
I
nﬂ  uenza A virus (H5N1) is the predominant candidate for 
a future inﬂ  uenza pandemic if it develops efﬁ  cient abil-
ity for human-to-human transmission. Since 2003, a total of 
109 human deaths have been associated with this strain (1). 
Monitoring the genetic structure of this virus is needed for 
predicting changes that may confer ability to cause pandem-
ics: pathogenicity, host range, and antigenic drift. 
Recently, 2 avian inﬂ  uenza A (H5N1) outbreaks oc-
curred in Turkey. The ﬁ  rst outbreak, in Balikesir in north-
western Turkey in October 2005, was limited to poultry. 
The second outbreak, in Dogubeyazit in northeastern Tur-
key in November 2005, involved poultry and humans. As 
of January 2006, a total of 12 human cases, 4 fatal, have 
been conﬁ  rmed (1). 
The Study
We analyzed molecular evolution of the virus genome 
by sequencing the hemagglutinin (HA), RNA polymerase 
(PB2), and matrix 2 (M2) genomic segments of 4 chicken 
and 2 human viral isolates. During the ﬁ  rst outbreak, the 
MYS viral isolate was obtained from a chicken. During 
the second outbreak, viral isolates SU, 13, and 20 were ob-
tained from chickens in southeastern Turkey, Anatolia, and 
Istanbul, respectively. Human viral isolates FK and MAK 
were obtained from 2 siblings who died shortly after the 
second outbreak. Changes in the viral genomes are sum-
marized in the Table.
Amino acids at positions 16, 13, 18, 20, 28, 55, and 
78 in M2 are associated with host speciﬁ   city; those at 
positions 31, 34, 26, 27, and 30 are associated with resis-
tance to adamantanes (2). All isolates in our study showed 
greatest homology to the M2 region of inﬂ  uenza A virus 
A/bar-headed goose/Qinghai /59/05 (H5N1) (GenBank ac-
cession no. AAZ16311). None of the isolates had amino 
acid changes associated with resistance to adamantanes. 
All chicken and human isolates from the second epidemic 
had a unique mutation (I42T) in the M2 region. Thus, the 
only difference between isolates from the 2 outbreaks is a 
mutation (T42) in isolates from the second outbreak. 
The HA sequence of MYS showed 98% homology 
with that of inﬂ  uenza A virus A/chicken/Kurgan/3/2005 
(H5N1) (GenBank accession no. DQ323672) and con-
tained a unique mutation (S133A) near receptor binding 
residue GVSSAC at positions 134 through 139. HA cleav-
age sites of all isolates from Turkey contained the sequence 
PQGERRRKKRGLF, similar to that of inﬂ  uenza A vi-
rus A/duck/Novosibirsk/ 56/2005(H5N1) (accession no. 
ABB17275), which indicates their high virulence. MAK 
contained mutations D158N and S227N in the HA region. 
These 2 mutations are important because D158N results in 
a potential glycosylation site and S227N enhances afﬁ  nity 
for human receptors.
Enhanced pathogenic potential of all avian and hu-
man inﬂ  uenza virus isolates from the second outbreak was 
shown by mutation E627K in the PB2 region. In addition, 
unique amino acid changes found only in human isolates 
were Q447L in FK and Q447L, R46K, and N556K in 
MAK. 
Conclusions
The Q447L and E627K mutations in FK and MAK vi-
rus isolates indicate a common origin of viruses in the 2 
siblings. Unique mutations (D158N and S227N in HA and 
N556K and R46K in PB2) in only the MAK isolate suggest 
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Table. Mutations in avian and human influenza A virus (H5N1) 
isolates from Turkey* 
Mutations
Isolate HA PB2 M2
FK† D158, S227  E627K, Q447L  I28V, I42T 
MAK† D158N, S227N  E627K, R46K, 
Q447L, N556K 
I28V, I42T 
MYS‡  D158, S133A, 
S227
I28V
SU§ D158, S227  E627K I28V, I42T 
13§ D158, S227  E627K I28V, I42T 
20§ D158, S227  E627K I28V, I42T 
*HA, hemagglutinin; PB2, RNA polymerase; M2, matrix 2 protein.  
†Human isolates from the second outbreak. 
‡Chicken isolate from the first outbreak. 
§Chicken isolates from the second outbreak. virus evolution in 1 patient. Human-to-human transmission 
and adaptation of the virus to infect humans have been sug-
gested (3). Incomplete knowledge of the history of infec-
tions in humans and lack of sample availability limited our 
study. Unique mutations in PB2, particularly in these hu-
man isolates, emphasize the need for clinical, epidemiolog-
ic, and molecular studies for further understanding of the 
global pattern of evolution of inﬂ  uenza A virus (H5N1).
The close location of mutation T42 to viral regions 
associated with host speciﬁ  city and resistance to adaman-
tanes and isolation of virus with this mutation from humans 
should be studied. Although isolates from the FK and MAK 
group have not been available for comparison, the unique 
changes should be studied with respect to their ability to 
confer survival advantage to virus in humans.
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